These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3021346

  • 1. Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinoma.
    Lelli G, Casadio M, Giuliotti C, Giordani S, Martoni A, Strocchi E, Pannuti F.
    Chemioterapia; 1986 Aug; 5(4):228-31. PubMed ID: 3021346
    [Abstract] [Full Text] [Related]

  • 2. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Aug; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 3. [Phase II studies of a single agent and a cis-platinum-based two-drug combination in patients with non-small cell lung cancer].
    Yamamoto M, Furuse K, Fukuoka M, Kawahara M, Arai R, Kodama N, Takada M, Negoro S, Matsui K, Ryu S.
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):487-92. PubMed ID: 2831821
    [Abstract] [Full Text] [Related]

  • 4. Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.
    Mantovani G, Macciò A, Mulas C, Massa E, Madeddu C, Mura L, Contu P, Versace R.
    Oncol Rep; 2002 Mar; 9(3):661-70. PubMed ID: 11956647
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Dose-response effect of drugs in the chemotherapy of small-cell bronchial carcinoma].
    Kostić D, Jelić S, Radulović S.
    Srp Arh Celok Lek; 2000 Mar; 128(3-4):75-9. PubMed ID: 10932613
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
    Figlin RA, Crowley JJ, Jacobs EL, Muirhead M, Goodwin JW, Rinehart JJ, Livingston RB.
    Cancer; 1996 Sep 01; 78(5):998-1003. PubMed ID: 8780537
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188.
    Lokich J, Auerbach M, Essig L, Fryer J, Fryer D.
    J Infus Chemother; 1995 Sep 01; 5(2):70-2. PubMed ID: 8521238
    [Abstract] [Full Text] [Related]

  • 14. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
    Berruti A, Terzolo M, Pia A, Angeli A, Dogliotti L.
    Cancer; 1998 Nov 15; 83(10):2194-200. PubMed ID: 9827725
    [Abstract] [Full Text] [Related]

  • 15. Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposide.
    Casadio M, Lelli G, Giordani S, Boltri B, Blotta A, Busutti L, Ramini R, Falcone F, Pannuti F.
    J Chemother; 1990 Jun 15; 2(3):199-202. PubMed ID: 2166145
    [Abstract] [Full Text] [Related]

  • 16. [Phase II study of a novel combination regimen composed of cisplatin, carboplatin and etoposide against unresectable non-small cell lung cancer].
    Sakurai M, Ichiki M, Ohashi Y, Hayashi I.
    Gan To Kagaku Ryoho; 1993 Mar 15; 20(4):499-502. PubMed ID: 8383950
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
    Joss RA, Alberto P, Obrecht JP, Barrelet L, Holdener EE, Siegenthaler P, Goldhirsch A, Mermillod B, Cavalli F.
    Cancer Treat Rep; 1984 Sep 15; 68(9):1079-84. PubMed ID: 6090014
    [Abstract] [Full Text] [Related]

  • 20. Weekly paclitaxel/cisplatin with concurrent radiotherapy in patients with locally advanced non-small cell lung cancer: a phase I study.
    Comella G, Frasci G, Scoppa G, Guida C, Gravina A, Fiore F, Casaretti R, Daponte A, Ruffolo P, Comella P.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-113-S12-116. PubMed ID: 9331134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.